Evidence map›Paper›PMID 20141541›Full record

ArticleImmunology2010

Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis.

Inga Wessels, Daniela Fleischer, Lothar Rink, Peter Uciechowski

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Immune senescence, epigenetics and autoimmunity.Clinical immunology (Orlando, Fla.) · 2018
    Review
  3. Interleukin-1 Beta-A Friend or Foe in Malignancies?International journal of molecular sciences · 2018
    Review
  4. Article
  5. Genetic and Epigenetic Regulation of Aortic Aneurysms.BioMed research international · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Inga WesselsInstitute of Immunology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Daniela Fleischer
Lothar Rink
Peter Uciechowski
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryInterleukin-1beta (IL-1beta) induces the expression of a variety of proteins responsible for acute inflammation and chronic inflammatory diseases. However, the molecular regulation of IL-1beta expression in myeloid differentiation has not been elucidated. In this study the chromatin structure of the IL-1beta promoter and the impact of methylation on IL-1beta expression in monocytic development were examined. The results revealed that the IL-1beta promoter was inaccessible in undifferentiated promyeloid HL-60 cells but highly accessible in differentiated monocytic cells which additionally acquired the ability to produce IL-1beta. Accessibilities of differentiated cells were comparable to those of primary monocytes. Lipopolysaccharide (LPS) stimulation did not affect promoter accessibility in promyeloid and monocytic HL-60 cells, demonstrating that the chromatin remodelling of the IL-1beta promoter depends on differentiation and not on the transcriptional status of the cell. Demethylation via 5-aza-2'-deoxycytodine led to the induction of IL-1beta expression in undifferentiated and differentiated cells, which could be increased after LPS stimulation. Our data indicate that the IL-1beta promoter is reorganized into an open poised conformation during monopoiesis being a privilege of mature monocytes but not of the entire myeloid lineage. As a second mechanism, IL-1beta expression is regulated by methylation acting independently of the developmental stage of myeloid cells.

Indexed as

AzacitidineCalcitriolCell DifferentiationCell Line, TumorChromatin Assembly and DisassemblyCytokinesDecitabineDNADNA MethylationDNA Modification MethylasesEnzyme InhibitorsGene ExpressionGene Expression Regulation, LeukemicHistone Deacetylase InhibitorsHL-60 CellsHumansAzacitidineCalcitriolCytokinesDecitabineDNADNA Modification MethylasesEnzyme InhibitorsHistone Deacetylase InhibitorsHydroxamic AcidsInterleukin-1betaLipopolysaccharide ReceptorsLipopolysaccharidesMicrococcal Nucleasetrichostatin A

Identifiers

PMID20141541
PMCPMC2913220
OpenAlexW1567737884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.